Massachusetts Financial Services
CNCE

Massachusetts Financial Services’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Massachusetts Financial Services’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-77,880
Closed -$984K – 981
2020
Q4 		$984K Sell
77,880
-780
-1% -$8.89K ﹤0.01% 796
2020
Q3 		$772K Sell
78,660
-3,083
-4% -$30.4K ﹤0.01% 794
2020
Q2 		$813K Buy
+81,743
New +$784K ﹤0.01% 745
2018
Q2 		– Sell
-12,892
Closed -$295K – 877
2018
Q1 		$295K Buy
+12,892
New +$287K ﹤0.01% 825

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services's CNCE Position: Q1 2021 in Review

Massachusetts Financial Services sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2021, closing a stake of 77,880 shares — an estimated $984K sold.

Massachusetts Financial Services first reported a position in CNCE in Q1 2018 and held it in 4 quarters. The position peaked at $984K in Q4 2020. 91 funds tracked by Wall St. Rank hold CNCE as of Q1 2021.

  • Massachusetts Financial Services reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Massachusetts Financial Services sold 77,880 Concert Pharmaceuticals, Inc. shares in Q1 2021, an estimated $984K.
  • Massachusetts Financial Services first reported a position in Concert Pharmaceuticals, Inc. in Q1 2018 and held it in 4 quarters.
  • Massachusetts Financial Services's Concert Pharmaceuticals, Inc. position peaked at $984K in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2021.

Based on Massachusetts Financial Services's 13F filing for Q1 2021, filed 13 May 2021.